AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2009

Aug 26, 2009

34915_dirs_2009-08-26_d32925fa-2e8a-4d70-bee6-ca7acc9c5116.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-08-24

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-08-24	Common Stock	S	12000	$0.86	Disposed	34448900	Direct
2009-08-25	Common Stock	S	10000	$0.91	Disposed	34438900	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour's Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.